Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Licenses Proteomics Technology from Large Scale Biology and Millennium

NEW YORK, Oct. 10 - Agilent Technologies said today it will license proteomics sample preparation technology from Large Scale Biology.

 

The agreement will allow Agilent to exclusively develop new technologies for the separation of low-abundance proteins from serum samples, said Agilent.

 

Financial details of the agreement were not disclosed.

 

In a separate deal, Agilent has licensed the right to exclusively develop and sell software based on Millennium Pharmaceuticals' SpectrumMill mass spectral analysis software. Agilent said the software will help its customers get more information from the company's mass spectrometry-based proteomics products.

 

The agreement gives Millennium early access to Agilent products and chemistries for proteomics research, according to Agilent.

 

The companies did not disclose financial details of the agreement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.